revumenib-REVUFORJ latest price and market reference cost in 2026
Revumenib-REVUFORJ is a new type of targeted drug mainly used for the treatment of hematological malignancies related to specific gene mutations. At present, Revimenib is not yet on the market in China. If patients need to use this drug, they mainly rely on overseas formal channels to obtain the original drug. The specifications of the overseas American version of the original drug include 110 mg 30 tablets and 160 mg 30 tablets. Each box is priced at about 200,000 yuan, which is very expensive. Therefore, ordinary patients have higher costs to obtain it at their own expense, and need to make financial budgets and treatment plans in advance.
In addition to the original drug, generic versions of Revimenib are already on the market in overseas markets. The ingredients of generic drugs are basically the same as those of original drugs, but the price is significantly lower than that of original drugs. Taking the Laos Lucius version as an example, 110mg30 tablets are priced at approximately 6200 yuan per box, and 160mg30 tablets are priced at approximately 8300 yuan per box. This kind of generic medicine provides domestic patients with a more economical and feasible choice, while ensuring the reliability of the drug ingredients and efficacy.

In terms of purchase channels, if domestic patients want to obtain Revemenib, they need to make formal purchases through overseas authorized pharmacies or cross-border medical channels. Before purchasing, you should ensure that the source is legal and follow the doctor's prescription instructions to ensure the source of the medicine is regular and the medication is safe. In addition, purchasing overseas drugs may involve transportation and customs management issues. Patients need to understand the relevant regulations in advance and arrange the purchase and transportation process reasonably.
Overall, Revimenib has not yet been launched in China, is expensive and has limited access. Original drugs are expensive and suitable for patients with relatively well-off financial conditions, while overseas generic drugs provide an economically feasible option for patients who require long-term treatment. During use, you should strictly follow the medication instructions of professional doctors, and regularly monitor hematological indicators and disease responses to ensure maximum drug efficacy and medication safety.
Reference materials:https://pubmed.ncbi.nlm.nih.gov/40204253/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)